The Ministry of Health is advising the public that “three separate recalls have been issued for semaglutide injection products supplied to the Bermuda market.” A Government spokesperson said, “These recalls relate to product impurities, incorrect dose display, and packaging errors that may result in patients receiving the wrong dose. All pharmacies and medical warehouses in Bermuda …